Literature DB >> 11751922

V490M, a common mutation in 3-phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme.

Steven Pind1, Elzbieta Slominski, Jill Mauthe, Kayla Pearlman, Kathryn J Swoboda, John A Wilkins, Patricia Sauder, Marvin R Natowicz.   

Abstract

A deficiency of 3-phosphoglycerate dehydrogenase (PHGDH) is a disorder of serine biosynthesis identified in children with congenital microcephaly, seizures, and severe psychomotor retardation. We report here the identification of the 1468G-->A (V490M) mutation of this gene in two siblings of an Ashkenazi Jewish family, providing further evidence that the V490M mutation is a common, panethnic cause of this deficiency. Using a novel, DNA-based diagnostic test, the mutation was not detected in 400 non-Jewish controls; one heterozygote was found among 400 persons of Ashkenazi Jewish ethnicity. Extensive biochemical studies were undertaken to characterize the effect of this mutation on enzyme activity, turnover, and stability. The V490M PHGDH yielded less than 35% of the activity observed for the wild-type enzyme when overexpressed by transient transfection or when comparing the endogenous activity in fibroblast cells from the patients with controls. Immunoblotting studies showed a comparable reduction in the level of immunoreactive PHGDH in cells expressing the mutant enzyme. Pulse-chase experiments with metabolically labeled PHGDH indicated that this resulted from an increased rate of degradation of the mutant enzyme following its synthesis. Thermolability analyses of mutant and wild-type enzyme activity revealed no significant differences. While others have proposed that the V490M mutation decreases the V(max) of the enzyme, we conclude that this mutation impairs the folding and/or assembly of PHGDH but has minimal effects on the activity or stability of that portion of the V490M mutant that reaches a mature conformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751922     DOI: 10.1074/jbc.M111419200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Treatment with amino acids in serine deficiency disorders.

Authors:  T J de Koning
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

2.  Inactivation of the 3-phosphoglycerate dehydrogenase gene in mice: changes in gene expression and associated regulatory networks resulting from serine deficiency.

Authors:  Shigeki Furuya; Kazuyuki Yoshida; Yuriko Kawakami; Jyung Hoon Yang; Tomoko Sayano; Norihiro Azuma; Hideyuki Tanaka; Satoru Kuhara; Yoshio Hirabayashi
Journal:  Funct Integr Genomics       Date:  2008-01-29       Impact factor: 3.410

3.  Reduction of stratum corneum ceramides in Neu-Laxova syndrome caused by phosphoglycerate dehydrogenase deficiency.

Authors:  Takuya Takeichi; Yusuke Okuno; Akane Kawamoto; Takeshi Inoue; Eiko Nagamoto; Chiaki Murase; Eri Shimizu; Kenichi Tanaka; Yuichi Kageshita; Satoshi Fukushima; Michihiro Kono; Junko Ishikawa; Hironobu Ihn; Yoshiyuki Takahashi; Masashi Akiyama
Journal:  J Lipid Res       Date:  2018-10-22       Impact factor: 5.922

4.  An update on serine deficiency disorders.

Authors:  S N van der Crabben; N M Verhoeven-Duif; E H Brilstra; L Van Maldergem; T Coskun; E Rubio-Gozalbo; R Berger; T J de Koning
Journal:  J Inherit Metab Dis       Date:  2013-03-06       Impact factor: 4.982

5.  A genome-wide perspective of genetic variation in human metabolism.

Authors:  Thomas Illig; Christian Gieger; Guangju Zhai; Werner Römisch-Margl; Rui Wang-Sattler; Cornelia Prehn; Elisabeth Altmaier; Gabi Kastenmüller; Bernet S Kato; Hans-Werner Mewes; Thomas Meitinger; Martin Hrabé de Angelis; Florian Kronenberg; Nicole Soranzo; H-Erich Wichmann; Tim D Spector; Jerzy Adamski; Karsten Suhre
Journal:  Nat Genet       Date:  2009-12-27       Impact factor: 38.330

6.  Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency.

Authors:  L Tabatabaie; L W J Klomp; M E Rubio-Gozalbo; L J M Spaapen; A A M Haagen; L Dorland; T J de Koning
Journal:  J Inherit Metab Dis       Date:  2010-11-27       Impact factor: 4.982

7.  Validating the inhibitory effects of d- and l-serine on the enzyme activity of d-3-phosphoglycerate dehydrogenases that are purified from Pseudomonas aeruginosa, Escherichia coli and human colon.

Authors:  Jun Okuda; Syouya Nagata; Masashi Yasuda; Chigusa Suezawa
Journal:  Gut Pathog       Date:  2019-06-30       Impact factor: 4.181

8.  Biochemical and Biophysical Characterization of Recombinant Human 3-Phosphoglycerate Dehydrogenase.

Authors:  Giulia Murtas; Giorgia Letizia Marcone; Alessio Peracchi; Erika Zangelmi; Loredano Pollegioni
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

9.  Characterization of ETFDH and PHGDH Mutations in a Patient with Mild Glutaric Aciduria Type II and Serine Deficiency.

Authors:  Amanat Ali; Nahid Al Dhahouri; Fatmah Saeed Ali Almesmari; Waseem Mahmoud Fathalla; Fatma Al Jasmi
Journal:  Genes (Basel)       Date:  2021-05-08       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.